<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The diagnosis of <z:hpo ids='HP_0100580'>Barrett's esophagus</z:hpo> and the different degrees of intraepithelial <z:hpo ids='HP_0002664'>neoplasia</z:hpo> appear to be demanding in several aspects </plain></SENT>
<SENT sid="1" pm="."><plain>Current data on genetic alterations involved in the <z:e sem="disease" ids="C0596263" disease_type="Neoplastic Process" abbrv="">carcinogenesis</z:e> of <z:hpo ids='HP_0100580'>Barrett's esophagus</z:hpo> are discussed </plain></SENT>
<SENT sid="2" pm="."><plain>Several new biomarkers are being tested to help better to determine the risk of <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> development </plain></SENT>
<SENT sid="3" pm="."><plain>However, a few immunohistochemical markers have emerged which could be helpful for the differential diagnosis of low- and high-grade intraepithelial <z:hpo ids='HP_0002664'>neoplasia</z:hpo> </plain></SENT>
<SENT sid="4" pm="."><plain>Markers which could predict the progression of premalignant Barrett's epithelium to <z:mp ids='MP_0002038'>carcinoma</z:mp> are still to be established </plain></SENT>
<SENT sid="5" pm="."><plain>At present, the "gold standard" for classifying the malignant potential in <z:hpo ids='HP_0100580'>Barrett's esophagus</z:hpo> is the degree of intraepithelial <z:hpo ids='HP_0002664'>neoplasia</z:hpo> found on standard biopsy protocols </plain></SENT>
</text></document>